ARCHIVES

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Eight Minority CCP Awards Confirmed, Four More Coming; General Motors Winners Named

June 15, 1990

Avastin Increases Overall Survival 3.7 Months

February 22, 2013

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

NCI Pilot to Speed Phase III Trials Deemed Unsuccessful, Will Be Shut Down

November 22, 2002

Executive Committee, Board of Scientific Advisors concur.

January 2, 2004